Net Reclassification Index and Integrated Discrimination Index Are Not Appropriate for Testing Whether a Biomarker Improves Predictive Performance.
Saved in:
| Title: | Net Reclassification Index and Integrated Discrimination Index Are Not Appropriate for Testing Whether a Biomarker Improves Predictive Performance. |
|---|---|
| Authors: | Burch PM; Pfizer Inc. Worldwide Research & Discovery, Groton, CT 06340., Glaab WE; Merck & Co, Inc, West, Point PA 19486., Holder DJ; Merck & Co, Inc, West, Point PA 19486., Phillips JA; Boehringer Ingelheim Pharmaceuticals Inc, Ridgefield, CT 06877., Sauer JM; Predictive Safety Testing Consortium, Critical Path Institute, Tucson, AZ 85718., Walker EG; Predictive Safety Testing Consortium, Critical Path Institute, Tucson, AZ 85718. |
| Source: | Toxicological sciences : an official journal of the Society of Toxicology [Toxicol Sci] 2017 Mar 01; Vol. 156 (1), pp. 11-13. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Oxford University Press Country of Publication: United States NLM ID: 9805461 Publication Model: Print Cited Medium: Internet ISSN: 1096-0929 (Electronic) Linking ISSN: 10960929 NLM ISO Abbreviation: Toxicol Sci Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| ISSN: | 1096-0929 |
|---|---|
| DOI: | 10.1093/toxsci/kfw225 |
